• Skip to main content
  • Skip to primary sidebar

  • Home
  • About
    • Overview
    • Owners and Intermediaries
    • Management Teams
    • Investors
  • Strategy
    • Overview
    • Disciplined Sector Focus
    • Long-Term Business Improvement
    • Investment Criteria & Transaction Profile
  • Sustainability
    • ESG Principles
    • Implementation
    • Core Areas
    • SK Portfolio EcoVadis Ratings
    • SKCP ESG Report
  • Portfolio
  • Team
  • News
  • Contact
  • Investor Login

Portfolio

/ June 1, 2017

Foremark

Foremark

Foremark Performance Chemicals is a technology-driven leader in natural gas sweetening applications and formalin manufacturing for chemical intermediates.  The Company leverages sustainable production processes to create chemistries and solutions that support the transition to clean energy, increase performance and  efficiency, and enhance modern life.  Foremark’s high automation plant in La Porte, Texas, is among the world’s largest and most efficient Triazine, Formalin and UFC (Urea Formaldehyde Concentrate) production facilities with operations delivering best-in-class yields and ultra low waste and emissions.

SK Capital acquired Foremark Performance Chemicals in May 2017.

For more information, please visit: www.foremarkperformance.com

Primary Sidebar

Related News

  • Foremark Performance Chemicals Awarded EcoVadis Silver Medal in Recognition for Sustainability Performance

    April 1, 2021
  • SK Capital Acquires D.B. Western, Inc. – Texas; Changes Name to Foremark Performance Chemicals

    June 1, 2017

SK Capital Portfolio Companies

  • Luxium Solutions
  • VanDeMark Chemical, Inc
  • Valtris Specialty Chemicals
  • Florachem
  • Heubach
  • Seqens
  • Deltech LLC
  • Canlak
  • IPACKCHEM
  • Woodstock Sterile Solutions
  • Lacerta Group
  • Venator
  • Tilley Distribution
  • NuCera Solutions
  • Techmer PM
  • GEON
  • SI Group
  • Perimeter Solutions
  • Wavelength
  • Foremark
  • Tri-Tex
  • Niacet
  • Noramco
  • Extractas Bioscience
  • Purisys
  • Archroma
  • Addivant
  • TPC Group
  • Ascend
  • IBA Molecular
  • Calabrian Corporation
  • Halo Pharmaceutical
  • AEB Group

To request for a copy of our ESG report, please click here.

© 2023 SK Capital Partners. All Rights Reserved.

Important Disclosures

  • Home
  • About
    • Overview
    • Owners and Intermediaries
    • Management Teams
    • Investors
    • Back
  • Strategy
    • Overview
    • Disciplined Sector Focus
    • Long-Term Business Improvement
    • Investment Criteria & Transaction Profile
    • Back
  • Sustainability
    • ESG Principles
    • Implementation
    • Core Areas
    • SK Portfolio EcoVadis Ratings
    • SKCP ESG Report
    • Back
  • Portfolio
  • Team
  • News
  • Contact
  • Investor Login